2137 — Brii Biosciences Share News
0.000.00%
Last trade - 00:00- HK$645.88m
- -HK$1.49bn
- CNY18.61m
Brief: Brii Biosciences Posts HY Revenue Rmb617,000
VBI Vaccines plunges on stock offerings
Brief: Brii Biosciences Says Entered Into License Agreements With VBI Vaccines
Brief: Vbi Vaccines And Brii Biosciences Expand Hepatitis B Partnership
Brief: Brii Biosciences Announces Agreements With Qpex And Disposal Of Equity Interests In Qpex
Over a dozen Chinese-based firms say they have minimal exposure to SVB (updated)
Six Hong Kong-listed firms say their deposits at SVB are immaterial
Brief: JPMorgan's Long Position In Ordinary Shares Of Brii Biosciences Rises To 5.07% - Filing
Brief: Invesco Advisers' Long Position In Ordinary Shares Of Brii Biosciences Falls To 5.87% - Filing
Brief: Yu Feng's Long Position In Ordinary Shares Of Brii Biosciences Falls To 5.53% - HKEX Filing
Brief: Ma Yun's Long Position In Ordinary Shares Of Brii Biosciences Falls To 5.93% - HKEX Filing
Brief: Brii Biosciences Updates On Strategic Clinical Development Progress
Factbox: China's approved COVID treatments
Brief: Shen Nan Peng's Long Position In Ordinary Shares Of Brii Biosciences Falls To 4.79% - HKEX Filings
Brief: Brii Biosciences Says Yongqing Luo To Resign As An Executive Director
Brief: Brii Biosciences Ltd Posts HY Loss Attributable Rmb347.6 Million
China's Brii Biosciences gains on positive data on its COVID treatment
Brief: Brii Biosciences Confirms Antibody Therapy Retains Neutralizing Activity Against Omicron Subvariants
Brief: Brii Biosciences Says TSB Therapeutics Partnering With China Resources Pharmaceutical Commercial